DrugDashboards

Clindamycin Phoaphate Topical Solution USP, 1%

Clindamycin Phosphate Topical Solution USP, 1% · CLINDAMYCIN PHOSPHATE 10 mg/mL · Solution · Topical · Northstar Rx LLC

NDC 72603-0321-02 · 1 BOTTLE in 1 CARTON / 60 mL in 1 BOTTLE · ANDA · View full market →

The short version

Just 2 companies supply this market — thin enough that a single exit would be felt immediately. The price is down 12% over the past year, to $0.1487 per mL. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$0.1$0.2Apr 2025Sep 2026$0.1487
18 price points · per MLSource: CMS NADAC

Estimated fill cost

WAC per package, as filed
$40.87
Reported to Texas DSHS · 2026 annual filing · Northstar Rx Llc

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicaid spend (2025)

$148,054
7,718 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

20Low risk

Some pressure is visible, but not much — here’s everything the score found to count.

  • 2 active manufacturers+20

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for clindamycin phosphate (other) in the next 90 days

sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
ANDA209914
TE code
AT
Approval date
Jan 28, 2019
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Clindamycin Phosphate Topical Solution USP, 1% (Solution)

LabelerStrengthFirst seenLast seen
Encube Ethicals, Inc.CLINDAMYCIN PHOSPHATE 10 mg/mLJul 15, 2026Sep 2, 2026
Northstar Rx LLCCLINDAMYCIN PHOSPHATE 10 mg/mLJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Clindamycin Phoaphate Topical Solution USP, 1% — NDC 72603-0321-02," retrieved September 3, 2026, https://drugdashboards.com/drug/72603032102.

Free to cite with attribution — see how the data is put together.